基于解释结构模型的我国生物医药创新能力影响因素分析

Analysis of influencing factors of China's biomedical innovation ability based on ISM

目的:针对我国生物医药创新能力亟需加强的现实需求,分析生物医药创新能力的影响因素,为加速生物医药行业创新发展提供指导。方法:综合情报调研和专家访谈梳理出我国生物医药创新能力的影响因素,运用解释结构模型分析影响因素之间的复杂关系,形成递接结构关系,提出政策环境、经费投入、技术平台、成果产出、创新力度五个层次的生物医药创新能力提升的运行机理。结果:我国生物医药创新能力以政策环境为基本保障,以经费投入和技术平台为发展基础,以成果产出和创新集聚效应为表现形式。结论:提升生物医药创新能力需要强化政策环境的保障支撑,加大经费投入和技术平台发挥的基础性作用,以及关注成果产出和创新集聚效应的正向反馈。

Objective:Focusing on the practical and urgent demand on the improvement of China's biomedical innovation ability,this paper analyzed the influencing factors of biomedical innovation ability,so as to provide guidance for accelerating the innovation and development of China's biomedical industry.Methods:Based on comprehensive information research and expert interviews,this paper delineated the influencing factors of China's biomedical innovation ability,used the Interpretative Structural Modeling to analyze the complex relationship among these influencing factors,formed a recursive structural relationship,and put forward an operation mechanism that can improve China's biomedical innovation ability from five aspects:policy environment,fund investment,technology platform,achievement output and innovation strength.Results:China's biomedical innovation ability is essentially guaranteed by the policy environment,its development is based on investment and technology platform,while its manifestation is in the form of achievement output and innovation agglomeration effect.Conclusions:To improve the biomedical innovation ability,it is crucial to strengthen the guaranteed support of policy environment,reinforce the fundamental functions of fund investment and technology platform,and focus on the positive feedback of achievement output and innovation agglomeration effect.